{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:47:55Z","timestamp":1776185275174,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.clinre.2013.03.011","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T05:01:50Z","timestamp":1368680510000},"page":"636-641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Proton-pump inhibitors can decrease gastrointestinal bleeding after percutaneous coronary intervention"],"prefix":"10.1016","volume":"37","author":[{"given":"Zongdan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaotao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kewei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2013.03.011_bib0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2013.03.011_bib0010","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"CREDO Investigators: Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.clinre.2013.03.011_bib0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinre.2013.03.011_bib0020","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjcard.2005.06.056","article-title":"Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes","volume":"96","author":"Rao","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinre.2013.03.011_bib0025","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.clinre.2013.03.011_bib0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjcard.2005.03.038","article-title":"Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction","volume":"96","author":"Abbas","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinre.2013.03.011_bib0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole Clopidogrel Aspirin) study","volume":"51","author":"Gilard","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinre.2013.03.011_bib0040","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1160\/TH08-12-0808","article-title":"Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel","volume":"101","author":"Sibbing","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinre.2013.03.011_bib0045","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ahj.2009.06.030","article-title":"Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents","volume":"158","author":"Ko","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinre.2013.03.011_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis in Myocardial Infarction (TIMI) trial\u2014phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinre.2013.03.011_bib0055","first-page":"e148","article-title":"ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clinre.2013.03.011_bib0060","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.107.188209","article-title":"2007 focused update of the ACC\/AHA 2004 guidelines for management of patients with ST-elevation myocardial infarction","volume":"117","author":"Antman","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clinre.2013.03.011_bib0065","first-page":"856","article-title":"Omeprazole affects clopidogrel efficacy but not ischemic events in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention","volume":"124","author":"Ren","year":"2011","journal-title":"Chin Med J"},{"key":"10.1016\/j.clinre.2013.03.011_bib0070","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"57","author":"Davi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2013.03.011_bib0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","article-title":"2007 focused update of the ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention","volume":"117","author":"King","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.clinre.2013.03.011_bib0080","first-page":"1792","article-title":"Economic evaluation of bivalirudin with provisional glycoprotein IIB\/IIIA inhibition versus heparin with routine glycoprotein IIB\/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial","volume":"44","author":"Cohen","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinre.2013.03.011_bib0085","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0195-668X(03)00485-8","article-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Moscucci","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinre.2013.03.011_bib0090","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1067\/mhj.2001.119371","article-title":"Predictors of length of stay after coronary stenting","volume":"142","author":"Aronow","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinre.2013.03.011_bib0095","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clinre.2013.03.011_bib0100","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/j.1572-0241.2007.01460.x","article-title":"Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study","volume":"102","author":"Chin","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2013.03.011_bib0105","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.jacc.2005.09.080","article-title":"Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial","volume":"47","author":"Kirtane","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinre.2013.03.011_bib0110","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2013.03.011_bib0115","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/eurheartj\/ehm194","article-title":"Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach","volume":"28","author":"Nikolsky","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinre.2013.03.011_bib0120","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.jacc.2008.12.073","article-title":"Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice","volume":"53","author":"Doyle","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinre.2013.03.011_bib0125","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.292.13.1555","article-title":"Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes","volume":"292","author":"Rao","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.clinre.2013.03.011_bib0130","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clinre.2013.03.011_bib0135","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","article-title":"Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry","volume":"113","author":"Spertus","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.clinre.2013.03.011_bib0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1253\/circj.69.331","article-title":"Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery","volume":"69","author":"Hata","year":"2005","journal-title":"Circ J"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740113000879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740113000879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:19:20Z","timestamp":1761895160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740113000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S2210740113000879"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2013.03.011","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton-pump inhibitors can decrease gastrointestinal bleeding after percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2013.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}